Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care

Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care

Liquid biopsy, specifically the analysis of circulating tumor DNA (ctDNA), offers a non-invasive approach for hepatocellular carcinoma (HCC) diagnosis and management. However, its implementation in the clinical setting is difficult due to challenges such as low ctDNA yield and difficulty in understa...

Full description

Bibliographic Details
Main Authors: Inah Marie C. Aquino, Devis Pascut
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Annals of Hepatology
Subjects:
Liquid biopsy
ctDNA
cfDNA
Artificial intelligence
HCC
CDSS
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812300279X

Similar Items

Similar Items